The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response

被引:1
|
作者
Rivas-Fuentes, Selma [1 ]
Salgado-Aguayo, Alfonso [2 ]
Santos-Mendoza, Teresa [1 ]
Sevilla-Reyes, Edgar [1 ]
机构
[1] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Lab Transcript & Mol Immunol, Mexico City 14080, Mexico
[2] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Lab Res Rheumat Dis, Mexico City 14080, Mexico
关键词
RSV; CX3CL1; CX3CR1; immune response; DENDRITIC CELLS; G-PROTEIN; CHEMOKINE FRACTALKINE; RECEPTOR CX3CR1; IN-VITRO; T-CELLS; B-CELLS; EXPRESSION; IDENTIFICATION; MONOCYTES;
D O I
10.3390/ijms25189800
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Respiratory syncytial virus (RSV) is a common respiratory pathogen that causes respiratory illnesses, ranging from mild symptoms to severe lower respiratory tract infections in infants and older adults. This virus is responsible for one-third of pneumonia deaths in the pediatric population; however, there are currently only a few effective vaccines. A better understanding of the RSV-host relationship at the molecular level may lead to a more effective management of RSV-related symptoms. The fractalkine (CX3CL1) receptor (CX3CR1) is a co-receptor for RSV expressed by airway epithelial cells and diverse immune cells. RSV G protein binds to the CX3CR1 receptor via a highly conserved amino acid motif (CX3C motif), which is also present in CX3CL1. The CX3CL1-CX3CR1 axis is involved in the activation and infiltration of immune cells into the infected lung. The presence of the RSV G protein alters the natural functions of the CX3CR1-CX3CL1 axis and modifies the host's immune response, an aspects that need to be considered in the development of an efficient vaccine and specific pharmacological treatment.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability
    Zhang, Xiaolin
    Feng, Xueyao
    Cai, Wenzhi
    Liu, Tengfei
    Liang, Zhenyang
    Sun, Ying
    Yan, Chenghui
    Han, Yaling
    THROMBOSIS RESEARCH, 2015, 135 (06) : 1147 - 1153
  • [42] Fractalkine/CX3CR1 and atherosclerosis
    Liu, Hong
    Jiang, Deqian
    CLINICA CHIMICA ACTA, 2011, 412 (13-14) : 1180 - 1186
  • [43] Prevention of lipopolysaccharide-induced preterm labor by the lack of CX3CL1-CX3CR1 interaction in mice
    Mizoguchi, Mika
    Ishida, Yuko
    Nosaka, Mizuho
    Kimura, Akihiko
    Kuninaka, Yumi
    Yahata, Tamaki
    Nanjo, Sakiko
    Toujima, Saori
    Minami, Sawako
    Ino, Kazuhiko
    Mukaida, Naofumi
    Kondo, Toshikazu
    PLOS ONE, 2018, 13 (11):
  • [44] The CX3CL1/CX3CR1 Reprograms Glucose Metabolism Through HIF-1 Pathway in Pancreatic Adenocarcinoma
    Ren, He
    Zhao, Tiansuo
    Sun, Junwei
    Wang, Xiuchao
    Liu, Jingcheng
    Gao, Song
    Yu, Ming
    Hao, Jihui
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (11) : 2603 - 2611
  • [45] Shedding light on the role of CX3CR1 in the pathogenesis of schizophrenia
    Chamera, Katarzyna
    Szuster-Gluszczak, Magdalena
    Basta-Kaim, Agnieszka
    PHARMACOLOGICAL REPORTS, 2021, 73 (04) : 1063 - 1078
  • [46] Baicalin exerts protective effects against lipopolysaccharide-induced acute lung injury by regulating the crosstalk between the CX3CL1-CX3CR1 axis and NF-κB pathway in CX3CL1-knockout mice
    Ding, Xin-Min
    Pan, Lei
    Wang, Yong
    Xu, Qin-Zhi
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 37 (03) : 703 - 715
  • [47] Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS
    Sarikidi, Anastasia
    Kefalakes, Ekaterini
    Falk, Christine S.
    Esser, Ruth
    Ganser, Arnold
    Thau-Habermann, Nadine
    Petri, Susanne
    BIOMEDICINES, 2022, 10 (11)
  • [48] CX3CR1 deficiency leads to impairment of immune surveillance in the epididymis
    Barrachina, F.
    Ottino, K.
    Tu, L. J.
    Soberman, R. J.
    Brown, D.
    Breton, S.
    Battistone, M. A.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (01)
  • [49] Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
    Cormican, Sarah
    Griffin, Matthew D.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [50] CX3CR1(+) B Cells Show Immune Suppressor Properties
    Wu, Zhiqiang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (33) : 22630 - 22635